FDA Establishment Registration for HCT/Ps: What It Means and What It Does Not Mean
One of the most common misconceptions surrounding Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) is the meaning of the phrase "FDA Registered." Because the term appears frequently in supplier documentation and product literature, it is often assumed to indicate that the FDA has reviewed, approved, certified, or endorsed a product. Under the regulatory framework governing many HCT/Ps, that assumption is incorrect.
FDA Establishment Registration is an administrative requirement that applies to certain establishments engaged in activities involving HCT/Ps regulated under 21 CFR Part 1271. Registration informs the FDA that an establishment performs regulated activities such as recovery, processing, storage, labeling, packaging, or distribution. It should not be interpreted as FDA approval, FDA clearance, a determination of safety or effectiveness, or an endorsement of any establishment or product.
This guide explains FDA Establishment Registration within the regulatory framework governing Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). It is provided for educational purposes only and should not be interpreted as legal advice, regulatory advice, or as an official FDA interpretation.
Understanding what FDA Establishment Registration does—and does not—mean is an important part of evaluating supplier documentation responsibly. Throughout this guide, you'll learn why establishments register, who is generally required to register, how registration relates to 21 CFR Part 1271, and why registration should never be confused with FDA approval.
Understanding FDA Establishment Registration
The infographic below summarizes how FDA Establishment Registration fits within the regulatory framework governing many Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). It highlights one of the most important concepts discussed throughout this guide:
FDA Establishment Registration is not the same as FDA Approval.
As you continue through this guide, each section expands on the concepts introduced in the infographic and explains how FDA Establishment Registration fits within the broader HCT/P regulatory framework.
On This Page
What Is FDA Establishment Registration?
FDA Establishment Registration is an administrative requirement within the federal regulatory framework that applies to certain establishments engaged in activities involving Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Registration provides the FDA with information about an establishment and the regulated activities it performs, supporting regulatory oversight and administrative transparency.
For many HCT/Ps regulated under Section 361 of the Public Health Service Act and 21 CFR Part 1271, registration helps the FDA identify establishments involved in activities such as recovery, processing, storage, labeling, packaging, and distribution. Registration is one component of a broader regulatory framework and should always be understood alongside donor eligibility, Current Good Tissue Practice (cGTP), quality systems, documentation, and traceability.
FDA Establishment Registration identifies certain regulated establishments and the activities they report to the FDA. It does not indicate that the FDA has approved a product, determined its safety or effectiveness, certified manufacturing quality, or endorsed an establishment.
Because the phrase "FDA Registered" is frequently used without additional explanation, healthcare professionals should understand both what registration communicates and what it does not. Registration provides important regulatory context, but it should always be evaluated as one component of a broader documentation review.
Why FDA Establishment Registration Exists
FDA Establishment Registration exists to support regulatory oversight by providing the FDA with current information about certain establishments performing regulated activities involving Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Rather than serving as a product evaluation process, registration creates administrative transparency regarding who is performing regulated activities within the HCT/P regulatory framework.
Maintaining accurate registration information allows the FDA to identify registered establishments and understand the types of HCT/P activities they report. Registration works alongside other regulatory requirements—including donor eligibility, Current Good Tissue Practice (cGTP), recordkeeping, quality systems, and product traceability—to support the broader framework established under 21 CFR Part 1271.
Understanding the purpose of registration helps healthcare professionals interpret supplier documentation more accurately. Registration identifies participation within the applicable regulatory system, but it should not be interpreted as evidence that the FDA has reviewed or approved an individual product.
FDA Establishment Registration identifies who is performing certain regulated activities. It does not determine whether a product has been approved, cleared, certified, or found to be safe or effective by the FDA.
Who Must Register?
Whether an establishment is required to register depends upon the activities it performs and the applicable federal regulations. In general, certain establishments engaged in the manufacture of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) are required to register with the FDA and submit HCT/P listings as required under 21 CFR Part 1271.
Examples of regulated activities that may require registration include:
- Recovery of HCT/Ps
- Processing and preservation
- Storage
- Labeling and packaging
- Distribution
- Donor screening and donor eligibility activities, where applicable
Registration requirements are based on the activities performed by an establishment—not on marketing language, product branding, or promotional claims. Because different organizations perform different functions, two FDA-registered establishments may have very different responsibilities within the HCT/P manufacturing process.
FDA Establishment Registration identifies an establishment within the regulatory framework. It should not be interpreted as evidence of FDA approval, manufacturing superiority, product quality, or clinical performance.
The FDA Establishment Registration Process
FDA Establishment Registration is not simply a one-time administrative filing. Establishments subject to registration requirements are generally responsible for submitting registration information, maintaining current records, and providing updates when required under the applicable regulations. These administrative requirements help ensure that FDA registration information remains current and accurately reflects the activities performed by the establishment.
Although the specific regulatory requirements are established under 21 CFR Part 1271, the registration process generally includes several key administrative components.
Initial Registration
An establishment subject to registration requirements submits identifying information to the FDA, including information about the establishment and the HCT/P-related activities it performs.
HCT/P Listing
Where applicable, establishments submit information identifying the Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) associated with their regulated activities. Product listings help the FDA understand the types of HCT/P activities reported by registered establishments.
Registration Updates
Registered establishments are generally responsible for updating registration information when required so FDA records continue to accurately reflect the establishment and its regulated activities.
Public Registration Information
The FDA maintains publicly available registration information that healthcare professionals may review as one component of supplier documentation. The presence of an establishment within the FDA registration database should not be interpreted as FDA approval, product endorsement, or a determination regarding product safety or effectiveness.
FDA Establishment Registration vs. FDA Approval
One of the most important regulatory distinctions for healthcare professionals is understanding the difference between FDA Establishment Registration and FDA Approval. Although these terms are often confused, they describe entirely different regulatory concepts and should never be used interchangeably.
FDA Establishment Registration identifies certain establishments performing regulated activities involving Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). FDA Approval refers to a separate regulatory pathway in which the FDA evaluates a product for a specific intended use under applicable statutory and regulatory authorities.
An establishment may be FDA registered without any product being FDA approved. Likewise, the statement "FDA Registered" should never be interpreted as meaning that the FDA has reviewed, approved, certified, endorsed, or determined the safety or effectiveness of a specific HCT/P.
| FDA Establishment Registration | FDA Approval |
|---|---|
| Administrative registration of certain establishments. | Formal FDA review under an applicable approval pathway. |
| Identifies regulated activities. | Evaluates evidence supporting a specific intended use. |
| Required for certain establishments under applicable regulations. | Applies only where an FDA approval pathway exists. |
| Does not determine product safety or effectiveness. | Represents a separate regulatory determination. |
| Does not constitute FDA endorsement. | Should never be confused with establishment registration. |
Understanding this distinction helps healthcare professionals evaluate supplier documentation more accurately and avoid one of the most common misunderstandings within the HCT/P industry.
Relationship to 21 CFR Part 1271
FDA Establishment Registration is one component of the broader regulatory framework governing many Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Registration works alongside other regulatory requirements established under 21 CFR Part 1271, each serving a different purpose within the overall framework.
Healthcare professionals reviewing supplier documentation should understand that FDA Establishment Registration, donor eligibility, Current Good Tissue Practice (cGTP), quality systems, documentation, and traceability are interconnected concepts. Together they provide context for understanding how many Section 361 HCT/Ps are regulated.
Registration and Current Good Tissue Practice (cGTP)
Current Good Tissue Practice establishes manufacturing, documentation, and quality-related requirements intended to reduce the risk of communicable disease transmission. FDA Establishment Registration identifies certain establishments within that regulatory framework but should not be interpreted as confirming compliance with every applicable cGTP requirement.
Learn more about Current Good Tissue Practice (cGTP) →
Registration and Donor Eligibility
Donor eligibility requirements address donor screening, donor testing, and relevant medical records where applicable. Registration does not replace donor eligibility requirements and should not be viewed as evidence that donor eligibility documentation has been independently evaluated by the FDA.
Learn more about Donor Eligibility →
Registration and Quality Systems
Quality systems provide the documented framework supporting operational consistency, traceability, documentation integrity, and quality oversight. Registration identifies certain establishments, while quality systems describe how regulated activities are managed and documented.
Common Misconceptions About FDA Establishment Registration
Because the phrase "FDA Registered" frequently appears in supplier documentation, websites, and educational materials, it is often misunderstood. Clarifying these common misconceptions helps healthcare professionals interpret regulatory documentation more accurately and avoid confusing administrative registration with other FDA regulatory pathways.
Misconception #1 — FDA Registered Means FDA Approved
This is incorrect. FDA Establishment Registration is an administrative regulatory requirement for certain establishments. It does not indicate that the FDA has approved, cleared, certified, or endorsed a product.
Misconception #2 — Registration Guarantees Product Safety or Effectiveness
Registration does not represent an FDA determination regarding product safety, effectiveness, or clinical performance. Those determinations involve separate regulatory pathways and should not be confused with establishment registration.
Misconception #3 — Every Registered Establishment Performs the Same Activities
Registered establishments may perform very different functions. One establishment may recover tissue, another may process tissue, while another may perform storage, labeling, packaging, or distribution. Registration identifies the establishment within the regulatory framework but does not describe every aspect of its operations.
Misconception #4 — Registration Replaces Documentation Review
FDA Establishment Registration is only one component of supplier evaluation. Healthcare professionals should also review donor eligibility documentation, Current Good Tissue Practice (cGTP), quality systems, product traceability, and other supporting records when evaluating Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).
Applying FDA Establishment Registration During Supplier Evaluation
FDA Establishment Registration should be viewed as one component of a broader documentation review rather than as a stand-alone indicator of quality. Registration provides important regulatory context, but it does not replace the need to evaluate the complete documentation package associated with an HCT/P.
When reviewing supplier documentation, registration helps answer one important administrative question:
Is this establishment identified within the FDA registration system for the regulated activities it reports?
Registration does not answer many of the additional questions healthcare professionals should consider before evaluating supplier documentation.
Questions Registration Helps Answer
- Is the establishment registered with the FDA where registration is applicable?
- What regulated activities has the establishment reported?
- Can the establishment be located within the FDA registration database?
- Does the supplier provide transparent regulatory documentation?
Questions Registration Does Not Answer
- Has the FDA approved this HCT/P?
- Has the FDA determined the product is safe or effective?
- Does registration verify manufacturing quality?
- Does registration predict clinical outcomes?
- Does registration replace supplier documentation review?
FDA Establishment Registration should be evaluated alongside the following documentation when reviewing an HCT/P supplier:
Frequently Asked Questions
What is FDA Establishment Registration?
FDA Establishment Registration is an administrative requirement that applies to certain establishments engaged in regulated activities involving Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Registration identifies the establishment and the regulated activities it reports to the FDA.
Does FDA Establishment Registration mean a product is FDA approved?
No. FDA Establishment Registration and FDA approval are separate regulatory concepts. Registration should not be interpreted as FDA approval, clearance, certification, endorsement, or a determination regarding product safety or effectiveness.
Can healthcare professionals verify FDA Establishment Registration?
Yes. The FDA maintains publicly available establishment registration information that may be reviewed as one component of supplier documentation.
Does every HCT/P establishment have to register?
Registration requirements depend upon the activities performed by the establishment and the applicable federal regulations.
Why do suppliers mention that they are FDA registered?
Registration is an important regulatory requirement for certain establishments and may appropriately appear within supplier documentation. Healthcare professionals should understand exactly what registration communicates and avoid assuming it represents FDA approval.
What additional documentation should be reviewed?
Registration should be evaluated together with donor eligibility records, Current Good Tissue Practice (cGTP), quality systems, traceability documentation, and other supporting regulatory records.
Is FDA Establishment Registration publicly searchable?
Yes. The FDA maintains public registration information for establishments subject to applicable registration requirements. Healthcare professionals may review this information as one component of supplier documentation; however, registration should not be interpreted as FDA approval or endorsement.
How often must registration information be updated?
Establishments subject to registration requirements are generally responsible for maintaining accurate registration information and submitting updates as required under the applicable regulations so FDA records remain current.
Does FDA registration indicate compliance with every regulatory requirement?
No. Registration identifies certain establishments within the regulatory framework but does not, by itself, demonstrate compliance with every applicable requirement under 21 CFR Part 1271. Healthcare professionals should evaluate registration together with donor eligibility documentation, Current Good Tissue Practice (cGTP), quality systems, and other supporting records.
Can two FDA-registered establishments perform different activities?
Yes. Registration reflects the regulated activities performed by an establishment. One establishment may recover tissue, another may process tissue, while another may perform storage, labeling, packaging, or distribution. Registration alone does not describe the complete scope of an establishment's operations.
Documentation & Regulatory Education
Licensed healthcare professionals seeking additional information regarding FDA Establishment Registration, supplier documentation, or regulatory evaluation may request educational resources and documentation review guidance.
Credential verification is required before access to certain manufacturer documentation.
Request Documentation Access →
Provider Credential Verification Portal →
This information is for educational purposes only.Not evaluated by the FDA.
Not intended to diagnose, treat, cure, or prevent any disease.
For use by licensed healthcare professionals.
Regulatory Notice
FDA Establishment Registration is an administrative regulatory requirement applicable to certain establishments engaged in activities involving Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Registration should not be interpreted as FDA approval, product clearance, certification, endorsement, or a determination regarding product safety or effectiveness.
This information is provided for educational purposes only.
Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. For use by licensed healthcare professionals.